New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
暂无分享,去创建一个
K. Dobberstein | C. Kramm | E. Chiocca | N. Rainov | M. Sena-Esteves | X. Breakefield | J. Hilton | U. Herrlinger | R. Philpot
暂无分享,去创建一个
K. Dobberstein | C. Kramm | E. Chiocca | N. Rainov | M. Sena-Esteves | X. Breakefield | J. Hilton | U. Herrlinger | R. Philpot